An investigation on behalf of investors of Cambrex Corporation (NYSE: CBM) in connection with the proposed takeover was announced and NYSE: CBM stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/14/2019 -- The takeover of Cambrex Corporation is under investigation concerning whether it is unfair to NYSE: CBM stockholders.
Investors who purchased shares of Cambrex Corporation (NYSE: CBM) and currently hold any of those NYSE: CBM shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain directors of Cambrex Corporation breached their fiduciary duties owed to NYSE: CBM investors in connection with the proposed acquisition.
East Rutherford, NJ based Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. On August 7, 2019, Cambrex Corporation(NYSE: CBM) announced that it has signed an agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex's net debt. Under the terms of the merger agreement, Cambrex shareholders will receive $60.00 in cash for each share of Cambrex common stock.
However, given that last year shares of Cambrex Corporation (NYSE: CBM) reached in the open market as high as $68.40 per share, the investigation concerns whether the offer is unfair to NYSE: CBM stockholders. More specifically, the investigation concerns whether the Cambrex Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
On August 13, 2019, NYSE: CBM shares closed at $60.10 per share.
Those who are current investors in Cambrex Corporation (NYSE: CBM) shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels